NCT01712074 Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil Status TERMINATED Phase PHASE2
NCT01708304 Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) Status COMPLETED Phase NA
NCT01703702 Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline Status COMPLETED Phase PHASE4
NCT01702480 Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects Status COMPLETED Phase PHASE1
NCT01702467 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01690195 Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01689246 Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01689233 Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01677754 A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy Status COMPLETED Phase PHASE2
NCT01677572 Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease Status TERMINATED Phase PHASE1
NCT01676935 This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01672827 Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images Status COMPLETED Phase PHASE3
NCT01662882 A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) Status COMPLETED Phase PHASE2/PHASE3
NCT01661894 Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly Status COMPLETED Phase PHASE1